Dynavax Technologies
Patents, Design & Utilities

Last updated:

List of all Dynavax Technologies patents 14 in total

Status Patent
Grant
Utility: Toll-like receptor antagonist compounds and methods of use External link
Filling date: 7 Sep 2025 Issue date: 28 Jun 2022
Application
Utility: ALKYL CHAIN MODIFIED IMIDAZOQUINOLINE TLR7/8 AGONIST COMPOUNDS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 3 Feb 2022
Application
Utility: IMMUNOGENIC COMPOSITION AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) External link
Filling date: 7 Sep 2025 Issue date: 7 Oct 2021
Grant
Utility: Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 21 Sep 2021
Application
Utility: COMBINATION OF A PD-1 ANTAGONIST AND CPG-C TYPE OLIGONUCLEOTIDE FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 1 Jul 2021
Grant
Utility: Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer External link
Filling date: 7 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 28 Jul 2020
Application
Utility: ALKYL CHAIN MODIFIED IMIDAZOQUINOLINE TLR7/8 AGONIST COMPOUNDS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 25 Jun 2020
Grant
Utility: Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 14 Apr 2020
Grant
Utility: Branched chimeric compounds, and methods of use thereof External link
Filling date: 7 Sep 2025 Issue date: 4 Feb 2020
Application
Utility: TOLL-LIKE RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USE External link
Filling date: 7 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME External link
Filling date: 7 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: BRANCHED CHIMERIC COMPOUNDS, AND METHODS OF USE THEREOF External link
Filling date: 7 Sep 2025 Issue date: 8 Aug 2019
Grant
Utility: Administration of polynucleotide toll-like receptor 9 agonists for treating cancer External link
Filling date: 7 Sep 2025 Issue date: 6 Aug 2019

Showing 1 to 14 of 14 patents.